Biography & Research:
Xue Hua, PhD has 20+ years research experience in Alzheimer’s clinical trials, biomarkers, neuroimaging, and neurology. From 2015-2022, she led a patient-centered research program at Athira Pharma, advancing Fosgonimeton (ATH-1017) across Phase I - III clinical trials for the treatment of Alzheimer’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. Prior to joining industry, Dr. Hua was an assistant professor at University of Southern California, developing imaging biomarkers to aid diagnosis and evaluation of Alzheimer’s disease and other neurological disorders. She received her PhD in Biomedical Engineering from the University of California, Los Angeles.